JP2008526996A5 - - Google Patents

Download PDF

Info

Publication number
JP2008526996A5
JP2008526996A5 JP2007551428A JP2007551428A JP2008526996A5 JP 2008526996 A5 JP2008526996 A5 JP 2008526996A5 JP 2007551428 A JP2007551428 A JP 2007551428A JP 2007551428 A JP2007551428 A JP 2007551428A JP 2008526996 A5 JP2008526996 A5 JP 2008526996A5
Authority
JP
Japan
Prior art keywords
substituted
unsubstituted
group
alkyl
alkynyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007551428A
Other languages
English (en)
Japanese (ja)
Other versions
JP5253815B2 (ja
JP2008526996A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/001341 external-priority patent/WO2006076644A2/en
Publication of JP2008526996A publication Critical patent/JP2008526996A/ja
Publication of JP2008526996A5 publication Critical patent/JP2008526996A5/ja
Application granted granted Critical
Publication of JP5253815B2 publication Critical patent/JP5253815B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2007551428A 2005-01-14 2006-01-13 ヘテロアリールスルホンアミドおよびｃｃｒ２ Expired - Lifetime JP5253815B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US64410305P 2005-01-14 2005-01-14
US60/644,103 2005-01-14
US74282105P 2005-12-06 2005-12-06
US60/742,821 2005-12-06
US75098505P 2005-12-16 2005-12-16
US60/750,985 2005-12-16
PCT/US2006/001341 WO2006076644A2 (en) 2005-01-14 2006-01-13 Heteroaryl sulfonamides and ccr2

Publications (3)

Publication Number Publication Date
JP2008526996A JP2008526996A (ja) 2008-07-24
JP2008526996A5 true JP2008526996A5 (enExample) 2012-05-17
JP5253815B2 JP5253815B2 (ja) 2013-07-31

Family

ID=36678244

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007551428A Expired - Lifetime JP5253815B2 (ja) 2005-01-14 2006-01-13 ヘテロアリールスルホンアミドおよびｃｃｒ２

Country Status (13)

Country Link
US (1) US20060173019A1 (enExample)
EP (3) EP1838674B9 (enExample)
JP (1) JP5253815B2 (enExample)
AT (1) ATE503741T1 (enExample)
AU (1) AU2006204750C1 (enExample)
CA (1) CA2594726C (enExample)
DE (1) DE602006020979D1 (enExample)
DK (2) DK2354126T3 (enExample)
ES (1) ES2440965T3 (enExample)
IL (1) IL184539A (enExample)
MX (1) MX2007008474A (enExample)
PL (2) PL2354126T3 (enExample)
WO (1) WO2006076644A2 (enExample)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1507756B1 (en) 2002-05-24 2015-07-22 Millennium Pharmaceuticals, Inc. Ccr9 inhibitors and methods of use thereof
DK1798223T4 (da) 2002-11-18 2014-09-22 Chemocentryx Inc Arylsulfonamider
JP2007537275A (ja) * 2004-05-12 2007-12-20 ケモセントリックス， インコーポレイテッド アリールスルホンアミド
US7622583B2 (en) 2005-01-14 2009-11-24 Chemocentryx, Inc. Heteroaryl sulfonamides and CCR2
KR101380448B1 (ko) * 2005-04-21 2014-04-11 메르크 세로노 에스. 에이. ２，３치환된 피라진 술폰아미드
GB0524786D0 (en) * 2005-12-05 2006-01-11 Glaxo Group Ltd Compounds
GB0526445D0 (en) * 2005-12-23 2006-02-08 Novartis Ag Organic compounds
US8519135B2 (en) * 2006-07-14 2013-08-27 Chemocentryx, Inc. Heteroaryl sulfonamides and CCR2/CCR9
US20100234364A1 (en) * 2006-07-14 2010-09-16 Arindrajit Basak Ccr2 inhibitors and methods of use thereof
EP2049515B1 (en) * 2006-07-14 2011-01-26 ChemoCentryx, Inc. Triazolyl pyridyl benzenesulfonamides as ccr2 or ccr9 modulators for the treatment of atherosclerosis
US7718683B2 (en) * 2006-07-14 2010-05-18 Chemocentryx, Inc. Triazolyl phenyl benzenesulfonamides
US20080076120A1 (en) * 2006-09-14 2008-03-27 Millennium Pharmaceuticals, Inc. Methods for the identification, evaluation and treatment of patients having CC-Chemokine receptor 2 (CCR-2) mediated disorders
JP2010518014A (ja) * 2007-01-31 2010-05-27 バーテックス ファーマシューティカルズ インコーポレイテッド キナーゼ阻害剤として有用な２−アミノピリジン誘導体
US7776877B2 (en) * 2007-06-22 2010-08-17 Chemocentryx, Inc. N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl) hetaryl arylsulfonamides
CA2692761C (en) * 2007-07-12 2013-04-30 Chemocentryx, Inc. Fused heteroaryl pyridyl and phenyl benzenesulfonamides as ccr2 modulators for the treament of inflammation
US8586748B2 (en) * 2008-04-09 2013-11-19 Boehringer Ingelheim International Gmbh 2-sulfonylamino-4-heteroaryl butyramide antagonists of CCR10
UA103319C2 (en) 2008-05-06 2013-10-10 Глаксосмитклайн Ллк Thiazole- and oxazole-benzene sulfonamide compounds
EA020460B1 (ru) 2009-01-12 2014-11-28 Пфайзер Лимитед Производные сульфонамида
ES2532356T3 (es) 2010-07-09 2015-03-26 Pfizer Limited N-sulfonilbenzamidas como inhibidores de los canales de sodio dependientes de voltaje
CN103201270B (zh) * 2010-08-03 2015-06-24 日本化学医药株式会社 P2x4受体拮抗剂
RU2013132650A (ru) * 2010-12-16 2015-01-27 Аллерган, Инк. Серные производные в качестве модуляторов хемокиновых рецепторов
ES2655090T3 (es) 2010-12-16 2018-02-16 Allergan, Inc. Derivados de 1,2-bis-sulfonamida como moduladores de receptores de quimiocinas
CA2852160A1 (en) 2011-10-28 2013-05-02 Galderma Research & Development New leukocyte infiltrate markers for rosacea and uses thereof
KR20150008891A (ko) * 2012-05-08 2015-01-23 앤빌 엘엘씨 알파 7 니코틴성 아세틸콜린 수용기 알로스테릭 조절제, 그의 유도체 및 그의 용도
MX2016007128A (es) 2013-12-02 2016-08-11 Chemocentryx Inc Compuestos del receptor 6 de quimiocina (ccr6).
WO2017007755A1 (en) 2015-07-06 2017-01-12 Rodin Therapeutics, Inc. Heterobicyclic n-aminophenyl-amides as inhibitors of histone deacetylase
LT3319959T (lt) 2015-07-06 2021-12-27 Alkermes, Inc. Histono deacetilazės hetero-halogeno inhibitoriai
SG10202012080UA (en) 2016-06-03 2021-01-28 Chemocentryx Inc Method of treating liver fibrosis
US10195188B2 (en) 2016-06-13 2019-02-05 Chemocentryx, Inc. Method of treating pancreatic cancer
US10251888B2 (en) 2016-06-13 2019-04-09 Chemocentryx, Inc. Method of treating pancreatic cancer
MX388165B (es) 2016-11-23 2025-03-19 Chemocentryx Inc Método para tratar glomeruloesclerosis segmentaria focal
PT3562821T (pt) 2016-12-28 2021-03-03 Minoryx Therapeutics S L Compostos de isoquinolina, métodos para a sua preparação e utilizações terapêuticas dos mesmos em condições associadas à alteração da atividade da beta-galactosidade
CN106854177B (zh) * 2017-01-04 2019-10-11 苏州健雄职业技术学院 一种6-氯-4-羟基吡啶-3-甲醛的制备方法
US10793567B2 (en) 2017-01-11 2020-10-06 Rodin Therapeutics, Inc. Bicyclic inhibitors of histone deacetylase
EA039417B1 (ru) 2017-08-07 2022-01-25 Родин Терапеутикс, Инк. Бициклические ингибиторы гистондеацетилазы
BR112020007183A2 (pt) 2017-10-11 2020-09-24 Chemocentryx, Inc. tratamento de glomeruloesclerose focal segmentado com antagonistas de ccr2
WO2021007386A1 (en) 2019-07-10 2021-01-14 Chemocentryx, Inc. Indanes as pd-l1 inhibitors
BR112022006279A2 (pt) 2019-10-16 2022-06-28 Chemocentryx Inc Heteroaril-bifenil aminas para o tratamento de doenças pd-l1
AU2020368393B2 (en) 2019-10-16 2026-01-08 Chemocentryx, Inc. Heteroaryl-biphenyl amides for the treatment of PD-L1 diseases
TW202237119A (zh) 2020-12-10 2022-10-01 美商住友製藥腫瘤公司 Ａｌｋ﹘５抑制劑和彼之用途
CN113248427B (zh) * 2021-06-01 2023-05-02 苏州大学 磺酰胺基烟酸衍生物、酰胺基烟酸衍生物及其制备方法和应用
WO2023031308A1 (en) * 2021-08-31 2023-03-09 Artica Therapeutics B.V. Ccr2 inhibitors
NL2037411B1 (en) * 2024-04-08 2025-10-31 Univ Leiden Protac compounds

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3901855A (en) * 1974-08-07 1975-08-26 Us Air Force Preparation of polybenzimidazoles
US4166452A (en) 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
US4256108A (en) 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4265874A (en) 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US4403607A (en) * 1980-05-09 1983-09-13 The Regents Of The University Of California Compatible internal bone fixation plate
JPS61113060A (ja) * 1984-11-08 1986-05-30 Fuji Photo Film Co Ltd ハロゲン化銀カラ−写真感光材料
ATE167473T1 (de) * 1990-08-20 1998-07-15 Eisai Co Ltd Sulfonamid-derivate
JPH06135934A (ja) * 1991-12-27 1994-05-17 Ishihara Sangyo Kaisha Ltd ピリジン誘導体又はその塩を含有するホスホリパーゼ▲ａ２▼阻害剤、抗炎症剤又は抗膵炎剤
US5514555A (en) 1993-03-12 1996-05-07 Center For Blood Research, Inc. Assays and therapeutic methods based on lymphocyte chemoattractants
US5571775A (en) * 1994-07-11 1996-11-05 Dowelanco N-aryl[1,2,4]triazolo[1,5-a]pyridine-2-sulfonamide herbicides
JP3421349B2 (ja) * 1996-02-22 2003-06-30 テュラリク インコーポレイテッド ペンタフルオロベンゼンスルホンアミドおよび類縁体
US5780488A (en) * 1996-04-03 1998-07-14 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
AR015104A1 (es) * 1996-11-13 2001-04-18 Dowelanco Compuestos de n-arilsulfilimina sustituidos, utiles como catalizadores en la preparacion de compuestos de n-arilarilsulfonamida; proceso para preparar dichos compuestos y su uso para catalizar dicha preparacion.
GB9803228D0 (en) * 1998-02-17 1998-04-08 Zeneca Ltd Chemical compounds
EP0937711A1 (de) * 1998-02-18 1999-08-25 Roche Diagnostics GmbH Neue Thiobenzamide, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
JP4327915B2 (ja) * 1998-03-30 2009-09-09 株式会社デ・ウエスタン・セラピテクス研究所 スルフォンアミド誘導体
US6380206B1 (en) * 1998-11-23 2002-04-30 Cell Pathways, Inc. Method of inhibiting neoplastic cells with 4,5-diaminopyrimidine derivatives
JP2000159665A (ja) * 1998-11-27 2000-06-13 Nippon Kayaku Co Ltd リウマチの予防または治療剤
US6294192B1 (en) 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
CA2376781A1 (en) * 1999-06-28 2001-01-04 Janssen Pharmaceutica N.V. Benzimidazoles and imidazopyridines as respiratory syncytial virus replication inhibitors
JP2001089412A (ja) * 1999-09-22 2001-04-03 Otsuka Pharmaceut Co Ltd ベンゼン誘導体またはその医薬的に許容される塩
AU2001243158A1 (en) * 2000-02-18 2001-08-27 Merck And Co., Inc. Inhibitors of prenyl-protein transferase
JP2001335714A (ja) * 2000-03-22 2001-12-04 Fuji Photo Film Co Ltd アゾ色素、その製造方法、インクジェット用インク、インクジェット記録方法
US6525051B2 (en) * 2000-03-27 2003-02-25 Schering Aktiengesellschaft N-heterocyclic derivatives as NOS inhibitors
JP2002036052A (ja) * 2000-07-25 2002-02-05 Sankyo Mfg Co Ltd 自動工具交換装置
US7468253B2 (en) 2001-06-07 2008-12-23 Chemocentryx, Inc. Method for multiple chemokine receptor screening for antagonists using RAM assay
DE60216606T2 (de) 2001-06-07 2007-04-05 Chemocentryx Inc., Mountain View Zellwanderungsassay
EP1453516A2 (de) * 2001-10-17 2004-09-08 Boehringer Ingelheim Pharma GmbH & Co.KG 5-substituierte 4-amino-2-phenylamino-pyrimdinderivate und ihre verwendung als beta-amyloid modulatoren
ATE312096T1 (de) * 2001-12-18 2005-12-15 Neue verbindungen
AU2003220401A1 (en) * 2002-03-18 2003-10-08 Bristol-Myers Squibb Company Uracil derivatives as inhibitors of tnf-alpha converting enzyme (tace) and matrix metalloproteinases
EP1507756B1 (en) * 2002-05-24 2015-07-22 Millennium Pharmaceuticals, Inc. Ccr9 inhibitors and methods of use thereof
US20070021466A1 (en) * 2002-11-18 2007-01-25 Solomon Ungashe CCR2 inhibitors and methods of use thereof
DK1798223T4 (da) * 2002-11-18 2014-09-22 Chemocentryx Inc Arylsulfonamider
WO2004056774A2 (en) * 2002-12-19 2004-07-08 Neurogen Corporation Substituted biphenyl-4-carboxylic acid arylamide analogues as capsaicin receptor modulators
WO2004058265A1 (en) * 2002-12-24 2004-07-15 Biofocus Plc Compound libraries of 2,3-substituted pyrazine derivatives capable of binding to g-protein coupled receptors
CA2526385C (en) * 2003-05-29 2008-07-22 Abbott Laboratories Continuous dosing regimen with abt-751
EP1643960A2 (en) * 2003-07-02 2006-04-12 Merck & Co., Inc. Arylsulfonamide derivatives
US7622583B2 (en) * 2005-01-14 2009-11-24 Chemocentryx, Inc. Heteroaryl sulfonamides and CCR2
US9715915B2 (en) 2014-10-30 2017-07-25 Samsung Electronics Co., Ltd. Magneto-resistive devices including a free layer having different magnetic properties during operations

Similar Documents

Publication Publication Date Title
JP2008526996A5 (enExample)
JP2011520815A5 (enExample)
JP2008510828A5 (enExample)
CA2594726A1 (en) Heteroaryl sulfonamides and ccr2
JP2005504789A5 (enExample)
JP2011529500A5 (enExample)
RU2006109108A (ru) Соединения, обладающие активностью антагонистов crth2 рецепторов
JP2007511504A5 (enExample)
JP2010540643A5 (enExample)
JP2006508970A5 (enExample)
JP2008525416A5 (enExample)
JP2008504304A5 (enExample)
JP2012021003A5 (enExample)
JP2006507355A5 (enExample)
JP2013504593A5 (enExample)
JP2007517044A5 (enExample)
JP2015508823A5 (enExample)
JP2006523681A5 (enExample)
JP2012521411A5 (enExample)
JP2014524441A5 (enExample)
RU2010101611A (ru) Полициклические производные гуанина и способы их применения
JP2012504608A5 (enExample)
JP2007509947A5 (enExample)
JP2006522824A5 (enExample)
JP2006508979A5 (enExample)